AstraZeneca Plc

AstraZeneca Plc

FILE PHOTO: Vial labelled "AstraZeneca coronavirus disease (COVID-19) vaccine" placed on displayed EU flag is seen in this illustration picture taken March 24, 2021. REUTERS/Dado Ruvic/Illustratio

EU sues AstraZeneca over breach of Covid-19 vaccine supply contract

AstraZeneca said in response that the legal action by the EU was without merit and pledged to defend itself strongly in court

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca

Questions about AstraZeneca jab linger

The production of line for vials of Covishield at the Serum Institute of India Ltd. Hadaspar plant in Pune, India, on Jan. 22. Photographer: Dhiraj Singh/Bloomberg

Covax expects full vaccine supplies from India's Serum in May, says Unicef

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca

Missteps could mar long-term credibility of AstraZeneca shot

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo

AstraZeneca expects EU drug regulator to approve Dutch vaccine factory late by early April

Medical staff members administer the AstraZeneca vaccine at La Nuvola (The Cloud) convention center that was temporarily turned into a COVID-19 vaccination hub, in Rome, Friday, March 19, 2021. Photo: AP

AstraZeneca vaccinations resume in Europe after clot scare

AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. Picture taken March 16, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

How worried should we be about reports of blood clots and AstraZeneca's vaccine?

A vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. REUTERS/Hannibal Hanschke

Health experts pore over AstraZeneca safety data as Europe reels from vaccine suspensions

File Photo: A member of the medical staff holds a vial of the Oxford-AstraZeneca COVID-19 vaccine at the Foch hospital in Suresnes, near Paris, France, February 8, 2021. REUTERS/Benoit Tessier

EU regulator ‘convinced’ AstraZeneca jab benefits outweigh risks

File Photo: A logo is pictured on the headquarters of the World Health Orgnaization (WHO) in Geneva, Switzerland, June 25, 2020. Photo: Reuters/Denis Balibouse

WHO: Vaccine rollout unaffected by concerns over AstraZeneca

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration

Netherlands halts use of AstraZeneca Covid-19 vaccine

FILE PHOTO: A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Spanish regions halt AstraZeneca shots over blood clot concerns

There was also a mock drill of conducting vaccination and reporting and review meetings at the block, district and state levels. Picture: Hindustan Times

No clotting case in India after Oxford dose